Reducing Barriers to Hepatitis C Treatment among Drug Users: An Integrated Hepatitis C Peer Education and Support Program

被引：41

作者：

Roose, Robert J. ^{[1
]}

Cockerham-Colas, Lauren ^{[1
]}

Soloway, Irene ^{[1
]}

Batchelder, Abigail ^{[2
]}

Litwin, Alain H. ^{[2
]}

机构：

[1] Albert Einstein Coll Med, Div Subst Abuse, Bronx, NY 10467 USA

[2] Albert Einstein Coll Med, Div Internal Med, Bronx, NY 10467 USA

来源：

JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED | 2014年 / 25卷 / 02期

关键词：

Hepatitis C; peer education; methadone; opiate agonist treatment; injection drug users; METHADONE-MAINTENANCE TREATMENT; VIRUS-INFECTION; UNITED-STATES; CARE; PREVENTION; PREVALENCE;

D O I：

10.1353/hpu.2014.0096

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

This report describes an innovative HCV Peer Educator Program that facilitates education, support, and engagement in HCV treatment among patients in an opioid treatment program. Integrating peer educators in a collaborative manner with close supervision holds promise as a model to reduce barriers to HCV treatment among drug users.

引用

页码：652 / 662

页数：11

共 15 条

[1] The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 [J].

Armstrong, Gregory L. ;

Wasley, Annemarie ;

Simard, Edgar P. ;

McQuillan, Geraldine M. ;

Kuhnert, Wendi L. ;

Alter, Miriam J. .

ANNALS OF INTERNAL MEDICINE, 2006, 144 (10) :705-714

[2]

Boyer JL, 2003, HIV CLIN TRIALS, V4, P55

[3] Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression [J].

Davis, Gary L. ;

Alter, Miriam J. ;

El-Serag, Hashem ;

Poynard, Thierry ;

Jennings, Linda W. .

GASTROENTEROLOGY, 2010, 138 (02) :513-U141

[4] Treatment of chronic hepatitis C in active drug users [J].

Davis, GL ;

Rodrigue, JR .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) :215-217

[5] Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users [J].

Edlin, BR ;

Kresina, TF ;

Raymond, DB ;

Carden, MR ;

Gourevitch, MN ;

Rich, JD ;

Cheever, LW ;

Cargill, VA .

CLINICAL INFECTIOUS DISEASES, 2005, 40 :S276-S285

[6] Is it justifiable to withhold treatment for hepatitis C from illicit-drug users? [J].

Edlin, BR ;

Seal, KH ;

Lorvick, J ;

Kral, AH ;

Ciccarone, DH ;

Moore, LD ;

Lo, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) :211-214

[7] Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence [J].

Hellard, Margaret ;

Sacks-Davis, Rachel ;

Gold, Judy .

CLINICAL INFECTIOUS DISEASES, 2009, 49 (04) :561-573

[8] Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: Challenges and opportunities [J].

Litwin, AH ;

Soloway, I ;

Gourevitch, MN .

CLINICAL INFECTIOUS DISEASES, 2005, 40 :S339-S345

[9] Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program [J].

Litwin, Alain H. ;

Harris, Kenneth A., Jr. ;

Nahvi, Shadi ;

Zamor, Philippe J. ;

Soloway, Irene J. ;

Tenore, Peter L. ;

Kaswan, Daniel ;

Gourevitch, Marc N. ;

Arnsten, Julia H. .

JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2009, 37 (01) :32-40

[10] Limited uptake of hepatitis C treatment among injection drug users [J].

Mehta, Shruti H. ;

Genberg, Becky L. ;

Astemborski, Jacquie ;

Kavasery, Ravi ;

Kirk, Gregory D. ;

Vlahov, David ;

Strathdee, Steffanie A. ;

Thomas, David L. .

JOURNAL OF COMMUNITY HEALTH, 2008, 33 (03) :126-133

← 1 2 →